FIELD: medicine.
SUBSTANCE: method is staged: 1) cervical canal scrapes and biopsy materials of the uterine cervix are used to recover DNA of human papilloma virus; 2) virus genotype is determined; 3) patients with HPV 16 positive CIN are sampled; 4) real-time PCR is used to determine the number of virus DNA copies and a degree of its integration with a host gene (a physical status); 5) a threshold level of the viral load is stated taking into account the physical status of the virus (6.5 lg HPV DNA copies 16 per one cell); 6) the patients are classified according to the determined threshold viral load and physical status of the virus (the episomal and integrated form); 7) the poorly predicted patients having the high viral load (≥6.5 lg DNA copies per one cell) are detected in the episomal form of the virus, while the low load (<6.5 lg DNA copies per one cell) is shown by the integrated form of the virus.
EFFECT: method enables the early prediction of the unfavourable course of cervical intraepithelial neoplasms and potential transition into cervical cancer.
3 cl, 2 dwg, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING THE CLINICAL OUTCOME OF LOCALLY ADVANCED FORMS OF CERVICAL CANCER | 2018 |
|
RU2674675C2 |
METHOD FOR PREDICTING THE RISK OF RECURRENCE IN HPV16-POSITIVE PATIENTS WITH SQUAMOUS INTRAEPITHELIAL HIGH-GRADE DISEASE ON THE BASIS OF DETERMINING THE PHYSICAL STATUS OF THE VIRUS | 2019 |
|
RU2719581C1 |
METHOD FOR RECURRENCE-FREE SURVIVAL AND OVERALL SURVIVAL IN HPV 16-POSITIVE CERVICAL CANCER PATIENTS | 2018 |
|
RU2694834C1 |
METHOD OF PREDICTING PROGRESSION OF MILD INTRAEPITHELIAL NEOPLASIA IN WOMEN OF YOUNG AND FIRST PERIOD OF MATURE AGE | 2014 |
|
RU2572340C1 |
METHOD FOR PREDICTION OF PROGRESSION OF LOW-GRADE CERVICAL SQUAMOUS INTRAEPITHELIAL LESION WITH UNDERLYING HUMAN PAPILLOMAVIRUS INFECTION | 2021 |
|
RU2766719C1 |
METHOD OF COMPLEX THERAPY OF PRE-INVASIVE AND INVASIVE CERVICAL CANCER | 2013 |
|
RU2560689C2 |
METHOD FOR PREVENTING PRECANCER RECURRENCE AND PRIMARY CERVICAL CANCER FOLLOWING ORGAN-PRESERVING TREATMENT BY DIAGNOSING AND TREATING HPV IN ANOGENITAL-OROPHARYNGEAL SPHERE IN SEXUAL PAIRS | 2020 |
|
RU2733934C2 |
METHOD OF COMBINED THERAPY OF CERVICAL DYSPLASIA ASSOCIATED WITH HUMAN PAPILLOMA VIRUSES | 2019 |
|
RU2701525C1 |
3,3'-DIINDOLYLMETHANE (METINDOL)-BASE VAGINAL SUPPOSITORY | 2006 |
|
RU2318510C1 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DYSPLASTIC PROCESSES OF CERVIX | 2008 |
|
RU2395281C2 |
Authors
Dates
2014-01-10—Published
2012-05-11—Filed